Table S1.
Association of the frequency of methylation occurrence of cg20907471 (PAX1) and average of cg22303211 and cg06675478 (SOX1) in cancer tissues to the clinical characteristics of 166 patients with CRC using TCGA datasets (n=166)
Characteristics | N |
SOX1
|
PAX1
|
||||||
---|---|---|---|---|---|---|---|---|---|
M | U | Methylated percentage | P-value | M | U | Methylated percentage | P-value* | ||
Age, years | 0.239 | 0.560 | |||||||
Mean (SD) [range] | 70 | (11.9) | (36–90) | ||||||
<50 | 15 | 7 | 8 | 46.67 | 3 | 12 | 20.00 | ||
50–70 | 61 | 42 | 19 | 68.85 | 21 | 40 | 34.43 | ||
>70 | 90 | 54 | 36 | 60.00 | 29 | 61 | 32.22 | ||
Gender | 0.631 | 0.617 | |||||||
Male | 83 | 53 | 30 | 63.86 | 28 | 55 | 33.73 | ||
Female | 83 | 50 | 33 | 60.24 | 25 | 58 | 30.12 | ||
M | 0.576 | 0.191 | |||||||
M0 | 142 | 88 | 54 | 61.97 | 43 | 99 | 30.28 | ||
M1 | 24 | 15 | 9 | 62.50 | 19 | 14 | 79.17 | ||
N | 0.329 | 0.209 | |||||||
N0 | 99 | 65 | 34 | 65.66 | 27 | 72 | 27.27 | ||
N1 | 32 | 20 | 12 | 62.50 | 14 | 18 | 43.75 | ||
N2 | 34 | 18 | 17 | 52.94 | 12 | 23 | 35.29 | ||
T | 0.310 | 0.834 | |||||||
T1 | 4 | 1 | 3 | 25.00 | 2 | 2 | 50.00 | ||
T2 | 35 | 24 | 11 | 68.57 | 10 | 25 | 28.57 | ||
T3 | 110 | 69 | 41 | 62.73 | 36 | 74 | 32.73 | ||
T4 | 17 | 9 | 8 | 52.94 | 5 | 12 | 29.41 | ||
Stage | 0.666 | 0.646 | |||||||
I | 32 | 22 | 10 | 68.75 | 9 | 23 | 28.13 | ||
II | 64 | 41 | 23 | 64.06 | 18 | 46 | 28.13 | ||
III | 45 | 25 | 20 | 55.56 | 16 | 29 | 35.56 | ||
IV | 24 | 15 | 10 | 62.50 | 10 | 15 | 41.67 | ||
CEA | 0.338 | 0.887 | |||||||
<9.7 | 78 | 46 | 32 | 58.97 | 26 | 52 | 33.33 | ||
>9.7 | 24 | 13 | 11 | 54.17 | 8 | 16 | 33.33 | ||
NA | 64 | 44 | 20 | 68.75 | 19 | 45 | 29.69 |
Note:
Calculated χ2 test.
Abbreviations: CEA, carcinoembryonic antigen; CRC, colorectal cancer; M, methylated; PAX1, paired boxed gene 1; SOX1, sex-determining region Y-related high-mobility group box 1; TCGA, The Cancer Genome Atlas; U, unmethylated.